Ticagrelor improves remodeling, reduce apoptosis, inflammation and fibrosis and increase the number of progenitor stem cells after mycardial infarction

Project: Other project

StatusActive
Effective start/end date8/20/166/15/20

Funding

  • AstraZeneca LP: $134,781.00